Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 18, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

MenopauseType 2 Diabetes

Interventions

DRUG

GLP-1 Receptor Agonist

Wegovy®

DRUG

Menopausal Hormone Therapy

Estradot® and Utrogestan®\* (in women with intact uterus\*)

Trial Locations (1)

RECRUITING

University Hospital Bern, Bern

All Listed Sponsors

lead

Lia Bally

OTHER